查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970708

全球凝血分析儀市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Coagulation Analyzer Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

凝血分析儀市場預計將從 2025 年的 54.3 億美元成長到 2034 年的 88.9 億美元，2026 年至 2034 年的複合年成長率為 5.63%。

由於血液和心血管疾病的發生率不斷上升，以及對精準診斷的需求日益成長，凝血分析儀的市場正在擴大。現代分析儀具備自動化功能，能夠更快地提供檢測結果並最大限度地減少人為誤差。先進試劑和微流體技術的整合進一步提高了靈敏度和特異性，使檢查室和診所能夠進行更準確的患者評估。

未來的成長將由就地檢驗平台驅動，該平台使臨床醫生能夠在門診和急診室等分散環境中進行凝血評估。人工智慧增強的數據分析和與電子健康記錄的整合可提高工作流程效率，而小型化分析儀則擴大了檢測的覆蓋範圍，即使在資源有限的環境中也能進行檢測。快速提供檢測結果的能力對於管理外科手術、抗凝血治療和重症治療性介入尤為重要。

研發投入正推動下一代分析儀的開發，這些分析儀具備多重偵測功能，可同時偵測多個參數。此外，永續性措施也影響設計創新，製造商致力於減少試劑消耗和廢棄物。凝血分析儀市場預計將持續發展，成為精準醫療的基礎，在日益多元化的醫療保健環境中，確保病患安全和有效疾病管理。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球凝血分析儀市場：依產品分類

  • 市場分析、洞察與預測
  • 分析器
  • 消耗品

第5章 全球凝血分析儀市場：依技術分類

  • 市場分析、洞察與預測
  • 機械的
  • 電化學
  • 光學的
  • 其他

第6章 全球凝血分析儀市場：依測驗類型分類

  • 市場分析、洞察與預測
  • APTT
  • D-二聚體
  • 纖維蛋白原
  • 凝血酶原
  • 其他

第7章 全球凝血分析儀市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 研究機構
  • 診斷中心
  • 其他

第8章 全球凝血分析儀市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers
    • Abbott Laboratories
    • Thermo Fischer Scientific
    • Instrumentation Laboratory
    • Sysmex Corporation
    • International Technidyne Corporation
    • Beckman Coulter Inc
    • Helena Laboratories
    • Meril Life Sciences Pvt. Ltd
簡介目錄
Product Code: VMR112110473

The Coagulation Analyzer Market size is expected to reach USD 8.89 Billion in 2034 from USD 5.43 Billion (2025) growing at a CAGR of 5.63% during 2026-2034.

The coagulation analyzer market is expanding in response to the rising prevalence of blood disorders, cardiovascular diseases, and the demand for precision diagnostics. Modern analyzers are equipped with automation capabilities, ensuring faster turnaround times and minimizing human error. The integration of advanced reagents and microfluidics is further improving sensitivity and specificity, enabling laboratories and clinics to achieve more accurate patient assessments.

Future growth will be driven by point-of-care testing platforms, allowing clinicians to conduct coagulation assessments in decentralized settings such as outpatient clinics and emergency departments. AI-enhanced data analysis and connectivity with electronic health records are streamlining workflow efficiency, while miniaturized analyzers are making testing more accessible across low-resource settings. The ability to provide rapid results is particularly critical in managing surgical procedures, anticoagulant therapies, and critical care interventions.

Investments in research are generating next-generation analyzers with multiplexing capabilities, allowing simultaneous detection of multiple parameters. Furthermore, sustainability initiatives are influencing design innovations, with manufacturers focusing on reducing reagent consumption and waste. The coagulation analyzer market is expected to continue its evolution as a cornerstone of precision medicine, ensuring patient safety and effective disease management in increasingly diverse healthcare environments.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Analyzer
  • Consumables

By Technology

  • Mechanical
  • Electrochemical
  • Optical
  • Others

By Test

  • APTT
  • D-Dimer
  • Fibrinogen
  • Prothrombin
  • Others

By End Use

  • Hospitals
  • Research Institutes
  • Diagnostic Centers
  • Others

COMPANIES PROFILED

  • F HoffmannLa Roche Ltd, Siemens Healthineers, Abbott Laboratories, Thermo Fischer Scientific, Instrumentation Laboratory, Sysmex Corporation, International Technidyne Corporation, Beckman Coulter Inc, Helena Laboratories, Meril Life Sciences Pvt Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL COAGULATION ANALYZER MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Analyzer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COAGULATION ANALYZER MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. Mechanical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Electrochemical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Optical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COAGULATION ANALYZER MARKET: BY TEST 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Test
  • 6.2. APTT Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. D-Dimer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Fibrinogen Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Prothrombin Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COAGULATION ANALYZER MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COAGULATION ANALYZER MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Technology
    • 8.2.3 By Test
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Technology
    • 8.3.3 By Test
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Technology
    • 8.4.3 By Test
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Technology
    • 8.5.3 By Test
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Technology
    • 8.6.3 By Test
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COAGULATION ANALYZER INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 F. Hoffmann-La Roche Ltd
    • 10.2.2 Siemens Healthineers
    • 10.2.3 Abbott Laboratories
    • 10.2.4 Thermo Fischer Scientific
    • 10.2.5 Instrumentation Laboratory
    • 10.2.6 Sysmex Corporation
    • 10.2.7 International Technidyne Corporation
    • 10.2.8 Beckman Coulter Inc
    • 10.2.9 Helena Laboratories
    • 10.2.10 Meril Life Sciences Pvt. Ltd